| Hans-Günter Meyer-Thompson | Diamorphin
Changes in daily dose in open-label compared to double-blind: The role of clients' expectations in injectable opioid agonist treatment.
Changes in daily dose in open-label compared to double-blind: The role of clients' expectations in injectable opioid agonist treatment.
Blawatt S, Arreola LAG, Magel T, MacDonald S, Harrison S, Schechter MT, Oviedo-Joekes E.
Addict Behav Rep. 2023 Apr 14;17:100490. doi: 10.1016/j.abrep.2023.100490. PMID: 37124402; PMCID: PMC10140796.